Alexander Knyazev

Alexander Knyazev has a diverse work experience in the pharmaceutical industry. ALEXANDER is currently working as the Medical Lead at Merz Therapeutics since January 2021. Prior to this, they served as the Head of Medical Department at STADA CIS from March 2020 to December 2020. Alexander also had a long tenure at Takeda, where they held various roles including Medical Head TA Primary Care, Medical Affairs Manager, and Senior Medical Advisor from 2012 to 2020. Before that, they worked as a Medical Scientific Advisor at Nycomed and UCB Pharma. ALEXANDER started their career as a Clinical Research Associate at Quintiles and then held the position of Research Fellow at the Moscow Regional Scientific Clinical Research Institute.

Alexander Knyazev has a strong educational background in both neuroscience and pediatrics. From 1994 to 2000, they attended the Russian State Medical University, where they earned a degree in Pediatrics. Following this, they pursued further education at the Moscow Regional Scientific Research Institute from 2000 to 2002, where they obtained a PhD in Neuroscience. In addition to their formal education, they also hold a certification in Neurology; however, the specific institution and attainment details are not provided.